BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28195618)

  • 1. Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma.
    Mohney BG; Elner VM; Smith AB; Harbour JW; Smith BD; Musch DC; Smith SJ
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):151-159. PubMed ID: 28195618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide as a virocidal anticytomegalovirus therapy: intravitreal toxicology and pharmacology in rabbits.
    Morlet N; Stayt J; Vaegan ; Salonikas C; Naidoo D; Crouch R; Graham G; Coroneo M
    Aust N Z J Ophthalmol; 1999 Oct; 27(5):342-9. PubMed ID: 10571395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
    Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.
    Kaczmarek JV; Bogan CM; Pierce JM; Tao YK; Chen SC; Liu Q; Liu X; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Friedman DL; Richmond A; Daniels AB
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):8. PubMed ID: 34757417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits.
    Khodabande A; Ghassemi F; Asadi Amoli F; Riazi-Esfahani H; Mahmoudzadeh R; Mehrpour M; Valipour N
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00814. PubMed ID: 34250764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma.
    Winter U; Buitrago E; Mena HA; Del Sole MJ; Laurent V; Negrotto S; Francis J; Arana E; Sgroi M; Croxatto JO; Djaballah H; Chantada GL; Abramson D; Schaiquevich P
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4382-93. PubMed ID: 26176875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
    Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma.
    Brodie SE; Munier FL; Francis JH; Marr B; Gobin YP; Abramson DH
    Doc Ophthalmol; 2013 Feb; 126(1):79-84. PubMed ID: 23143758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
    Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
    Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A; Kao LY; Liu L; Wang NK
    BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
    Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
    Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intravitreal topotecan toxic to retinal function?
    Nadelmann J; Francis JH; Brodie SE; Muca E; Abramson DH
    Br J Ophthalmol; 2021 Jul; 105(7):1016-1018. PubMed ID: 32665221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach.
    Daniels AB; Froehler MT; Nunnally AH; Pierce JM; Bozic I; Stone CA; Santapuram PR; Tao YK; Boyd KL; Himmel LE; Chen SC; Du L; Friedman DL; Richmond A
    Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):954-964. PubMed ID: 30882851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: A Phase I Clinical Trial.
    King BA; Wilson MW; Kaluzny T; Meredith C; Overbey-Canon J; Chiang J; Brennan RC
    Ophthalmol Retina; 2023 Apr; 7(4):354-359. PubMed ID: 36372348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal toxicity after repeated intravitreal carboplatin injection into rabbit eyes.
    Pochop P; Darsova D; Uhlik J; Lestak J; Kukacka J; Kodetova D; Klapkova E; Malis J; Vajner L
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):552-6. PubMed ID: 23235724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma.
    Hsieh T; Liao A; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
    PLoS One; 2020; 15(7):e0235016. PubMed ID: 32609726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.